The author, Adam J. Fein, Ph.D. Dr. Fein is CEO of Drug Channels Institute  shared an updated chart on the vertical integration among insurers, PBMs, specialty pharmacies, and providers in the US drug channels, which was previously presented at Asembia's Specialty Pharmacy Summit.

The chart includes major business relationships among the largest companies, such as Blue Cross Blue Shield, Centene, Cigna, CVS Health, Elevance Health, Humana, and United Health Group, which are estimated to account for at least half of all public and private healthcare spending in the US. The chart is now available for viewing, and the author expects that vertical integration will be discussed during the Senate hearing on insulin. The chart is also included in the author's 2023 Economic Report on US Pharmacies and Pharmacy Benefit Managers.

Full article is on Drug Channels Institute here.